Skip to content

Clinical trials

Autistic Disorder trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autistic Disorder Country / region: Australia Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20171
20221
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
MapLight Therapeutics2
Bayside Health1
Fenix Innovation Group1
Forest Laboratories1
Karuna Therapeutics, Inc., a Bristol Myers Squibb company1
Ottawa Hospital Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autistic Disorder7
Autism Spectrum Disorder5
Asperger Syndrome2
Asthma1
Child Development Disorders, Pervasive1
Death1
Marijuana Abuse1
Mental Disorders1
Neurologic Manifestations1
Pre-Eclampsia1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.